These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19666905)

  • 1. Four cases of pancreatic acinar cell carcinoma treated with gemcitabine or S-1 as a single agent.
    Seki Y; Okusaka T; Ikeda M; Morizane C; Ueno H
    Jpn J Clin Oncol; 2009 Nov; 39(11):751-5. PubMed ID: 19666905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Rare Pancreatic Tumor That Underwent a Change in Morphology and Histopathologic Features During Chemotherapy.
    Seino S; Tsuchiya A; Natsui M
    Gastroenterology; 2016 Feb; 150(2):e11-3. PubMed ID: 26718170
    [No Abstract]   [Full Text] [Related]  

  • 3. A case of gemcitabine-refractory pancreatic cancer responsive to second-line chemotherapy using S-1.
    Morizane C
    Jpn J Clin Oncol; 2007 Dec; 37(12):973. PubMed ID: 18211987
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case of pancreatic acinar cell carcinoma with a giant liver metastasis successfully treated with combination of gemcitabine and peroral S-1].
    Nishimizu T; Minemura M; Kajiura S; Tokimitsu Y; Itaya Y; Yamawaki H; Kawai K; Tajiri K; Nakayama Y; Hosokawa A; Takahara T; Yasumura S; Shimizu S; Fukuoka J; Ishizawa S; Sawasaki T; Yanagisawa A; Sugiyama T
    Gan To Kagaku Ryoho; 2011 Feb; 38(2):309-12. PubMed ID: 21368502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case report of mixed acinar-endocrine carcinoma of the pancreas treated with S-1 chemotherapy: Does it work or induce endocrine differentiation?
    Yokode M; Itai R; Yamashita Y; Zen Y
    Medicine (Baltimore); 2017 Nov; 96(45):e8534. PubMed ID: 29137060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic Acinar Cell Carcinoma with Multiple Liver Metastases Effectively Treated by S-1 Chemotherapy.
    Yoshida N; Kanno A; Masamune A; Nabeshima T; Hongo S; Miura S; Takikawa T; Hamada S; Kikuta K; Kume K; Ueno M; Shimosegawa T
    Intern Med; 2018 Dec; 57(24):3529-3535. PubMed ID: 30101903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective multicenter study to investigate the introduction rate of second-line S-1 in gemcitabine-refractory unresectable pancreatic cancer.
    Kawashima H; Itoh A; Ohno E; Nakamura M; Miyahara R; Ohmiya N; Hara K; Kanamori A; Itoh T; Taki T; Hirai T; Hashimoto S; Takeda K; Goto H; Hirooka Y
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):677-83. PubMed ID: 21132496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acinar cell carcinoma of the pancreas: a possible role of S-1 as chemotherapy for acinar cell carcinoma. A case report.
    Yamamoto T; Ohzato H; Fukunaga M; Imamura H; Furukawa H
    JOP; 2012 Jan; 13(1):87-90. PubMed ID: 22233955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-1 monotherapy as second-line treatment for advanced pancreatic cancer after gemcitabine failure.
    Todaka A; Fukutomi A; Boku N; Onozawa Y; Hironaka S; Yasui H; Yamazaki K; Taku K; Machida N; Sakamoto T; Tomita H
    Jpn J Clin Oncol; 2010 Jun; 40(6):567-72. PubMed ID: 20189975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for adenocarcinoma of the body or tail of the pancreas.
    Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Ohge H; Sueda T
    J Gastrointest Surg; 2009 Jan; 13(1):85-92. PubMed ID: 18704593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemcitabine and S-1 combination chemotherapy versus gemcitabine alone for locally advanced and metastatic pancreatic cancer: a meta-analysis of randomized controlled trials in Asia.
    Li Y; Sun J; Jiang Z; Zhang L; Liu G
    J Chemother; 2015 Aug; 27(4):227-34. PubMed ID: 25790948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A Case of Gemcitabine Refractory Lung Metastasis after Distal Pancreatectomy for Pancreatic Cancer, Effectively Treated with S -1 as Second Line Chemotherapy].
    Omori K; Wakabayashi K; Suematsu Y; Suda H; Hiratsuka M; Takahashi M; Saito H; Ishibashi Y; Morita A; Ito Y
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1582-4. PubMed ID: 26805103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of pancreatic cancer treated by gemcitabine with sequential radiotherapy].
    Hisama S; Kimura M; Nishimura T; Matsushita H; Okamura S; Saitoh S; Shimokawa Y; Arakawa A; Toyama H; Tanaka Y
    Gan To Kagaku Ryoho; 2010 Jul; 37(7):1337-9. PubMed ID: 20647722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of S-1 in patients with gemcitabine-resistant advanced pancreatic cancer.
    Sudo K; Yamaguchi T; Nakamura K; Denda T; Hara T; Ishihara T; Yokosuka O
    Cancer Chemother Pharmacol; 2011 Feb; 67(2):249-54. PubMed ID: 20352216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A partial response to S-1 as second-line chemotherapy in a patient with unresectable pancreatic cancer].
    Egawa T; Ohashi M; Ito Y; Mihara K; Takahashi T; Hayashi S; Nagashima A
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2422-4. PubMed ID: 20037443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival following pancreatectomy and s-1 chemotherapy for pancreatic acinar cell carcinoma with peritoneal dissemination: a case report and literature review.
    Sumiyoshi T; Shima Y; Okabayashi T; Kozuki A; Iwata J; Saisaka Y; Tokumaru T; Nakamura T; Morita S
    Medicine (Baltimore); 2015 Jan; 94(1):e378. PubMed ID: 25569665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of S-1 in patients with gemcitabine-refractory pancreatic cancer in Japan.
    Nakai Y; Isayama H; Sasaki T; Sasahira N; Kogure H; Hirano K; Tsujino T; Ijichi H; Tateishi K; Tada M; Omata M; Koike K
    Jpn J Clin Oncol; 2010 Aug; 40(8):774-80. PubMed ID: 20462979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer.
    Ueno M; Okusaka T; Omuro Y; Isayama H; Fukutomi A; Ikeda M; Mizuno N; Fukuzawa K; Furukawa M; Iguchi H; Sugimori K; Furuse J; Shimada K; Ioka T; Nakamori S; Baba H; Komatsu Y; Takeuchi M; Hyodo I; Boku N
    Ann Oncol; 2016 Mar; 27(3):502-8. PubMed ID: 26681680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of S-1 monotherapy for older patients with unresectable pancreatic cancer: A retrospective cohort study.
    Harano Y; Babazono A; Fujita T; Jiang P
    J Geriatr Oncol; 2019 May; 10(3):420-426. PubMed ID: 30236507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of liver metastasis of pancreatic acinar cell carcinoma treated with S-1 and intra-arterial CDDP combination therapy].
    Fujii M; Sato H; Ogasawara T; Ando T; Tsujii S; Nagahori J; Komatsu Y; Matsuoka A
    Gan To Kagaku Ryoho; 2010 Oct; 37(10):1987-90. PubMed ID: 20948270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.